You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Medtronic
AstraZeneca
Baxter
Mallinckrodt

Last Updated: April 10, 2021

DrugPatentWatch Database Preview

ADEFOVIR DIPIVOXIL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Adefovir Dipivoxil patents expire, and what generic alternatives are available?

Adefovir Dipivoxil is a drug marketed by Apotex and Sigmapharm Labs Llc and is included in two NDAs.

The generic ingredient in ADEFOVIR DIPIVOXIL is adefovir dipivoxil. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the adefovir dipivoxil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Adefovir Dipivoxil

A generic version of ADEFOVIR DIPIVOXIL was approved as adefovir dipivoxil by SIGMAPHARM LABS LLC on August 29th, 2013.

  Start Trial

Drug patent expirations by year for ADEFOVIR DIPIVOXIL
Drug Prices for ADEFOVIR DIPIVOXIL

See drug prices for ADEFOVIR DIPIVOXIL

Recent Clinical Trials for ADEFOVIR DIPIVOXIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
New Discovery LLCPhase 4
Taipei Veterans General Hospital, TaiwanPhase 4
National Health and Family Planning Commission, P.R.ChinaPhase 4

See all ADEFOVIR DIPIVOXIL clinical trials

Paragraph IV (Patent) Challenges for ADEFOVIR DIPIVOXIL
Tradename Dosage Ingredient NDA Submissiondate
HEPSERA TABLET;ORAL adefovir dipivoxil 021449 2010-06-08

US Patents and Regulatory Information for ADEFOVIR DIPIVOXIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex ADEFOVIR DIPIVOXIL adefovir dipivoxil TABLET;ORAL 205459-001 Jul 6, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Sigmapharm Labs Llc ADEFOVIR DIPIVOXIL adefovir dipivoxil TABLET;ORAL 202051-001 Aug 29, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Boehringer Ingelheim
Mallinckrodt
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.